MENÚ

PMSDDS 2025

CureSHANK 2nd Annual Phelan-McDermid Syndrome Drug Development Symposium

Parc de Recerca Biomèdica Barcelona / June 26-27

cureshank

Organized by

Sponsored by

Organizing Committee

Geraldine Bliss, MS
Founder and President – CureSHANK

Norma Alhambra
President – Spanish Phelan-McDermid Syndrome Association

Ignasi Andreu
Board Member – Spanish Phelan-McDermid Syndrome Association

Catalina Betancur, MD, PhD
Director of Research, INSERM, CNRS, Sorbonne University, Paris, France
Chair, Scientific Advisory Board, Spanish Phelan-McDermid Syndrome Association

Ana Mingorance, PhD
Chief of Translational Science – CureSHANK

Michael Schön, MD
Neuroscientist – Institute for Anatomy and Cell Biology, Ulm University
Chair of the European PMS Research Consortium

Federico Bolognani, MD, PhD
Co-founder, Chief Medical Officer – Newleos Therapeutics

Constance Colin
Coordinator – Spanish Phelan-McDermid Syndrome Association